Clinton has not been as specific, indicating she will roll out her plans over time. She has offered cost reduction proposals such as computerized medical records and emphasis on disease prevention and drug purchasing plans to reduce the price of medicines.
Her deliberate pace has not hurt her with health professionals or even with some drug manufacturers.
She received $4,600 from Kevin Sharer, the chairman, chief executive and president of Amgen, a California-based pharmaceutical company. Sharer also gave $4,000 to McCain and $2,300 to Romney.
Sheila Krumholz, the center's executive director, cautioned about reading too much into contribution figures. Donors at this stage are more likely to be driven by personal ideology, she said, than by industry considerations.
"I'm not sure this can be attributed to an industrywide shift," she said.
It could be the first hint of one, however.
"Surely, ideology is important to them, but they
are also political investors," Oberlander said. "I assume they want
to make sure they have ties political and financial to candidates they see as
plausibly winning the White House in 2008, even if that candidate's ideology
doesn't exactly match their own."
- Associated Press
© Copyright 2005 by DiverseEducation.com
